BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol. 1992;98:135-140. [PMID: 1732379 DOI: 10.1111/1523-1747.ep12555654] [Cited by in Crossref: 107] [Cited by in F6Publishing: 81] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Bolz S, Jappe U, Hartschuh W. Successful treatment of perifolliculitis capitis abscedens et suffodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges 2008;6:44-7. [PMID: 17908178 DOI: 10.1111/j.1610-0387.2007.06399.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Boccellino M, Quagliuolo L, Alaia C, Grimaldi A, Addeo R, Nicoletti GF, Kast RE, Caraglia M. The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity. Current Medical Research and Opinion 2016;32:1839-48. [DOI: 10.1080/03007995.2016.1211522] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
3 Wedi B, Novacovic V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression--inhibitory effects ofanti-inflammatory drugs. J Allergy Clin Immunol 2000;105:552-60. [PMID: 10719307 DOI: 10.1067/mai.2000.104939] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 4.1] [Reference Citation Analysis]
4 Faghihi G, Rakhshanpour M, Abtahi-Naeini B, Nilforoushzadeh MA. The efficacy of 5% dapsone gel plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: A randomized double-blind study. Adv Biomed Res 2014;3:177. [PMID: 25250291 DOI: 10.4103/2277-9175.139413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Wang C, Li Q, Li T. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways. Exp Lung Res 2020;46:11-22. [PMID: 31931639 DOI: 10.1080/01902148.2020.1711830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Peterson CM, Ahkavan M, Fernandez-soto ML, Rowell C, Scott BK, Peterson KP. Dapsone at Onset of Diabetes Lowers Glycated Hemoglobin and Delays Death in NOD Mice. Autoimmunity 2009;28:157-61. [DOI: 10.3109/08916939808996284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Scully C, Carrozzo M, Gandolfo S, Puiatti P, Monteil R. Update on mucous membrane pemphigoidA heterogeneous immune-mediated subepithelial blistering entity. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 1999;88:56-68. [DOI: 10.1016/s1079-2104(99)70194-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
8 Morgan M, Cooke A, Rogers L, Adams-Huet B, Khan DA. Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria. J Allergy Clin Immunol Pract 2014;2:601-6. [PMID: 25213055 DOI: 10.1016/j.jaip.2014.06.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
9 Nayar M, Wojnarowska F. Cicatricial pemphigoid: a re-evaluation of therapy. Journal of Dermatological Treatment 2009;4:89-93. [DOI: 10.3109/09546639309084522] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
10 Lee KH, Park JH, Kim DH, Hwang J, Lee G, Hyun JS, Heo ST, Choi JH, Kim M, Kim M, Kim SI, Eisenhut M, Kronbichler A, Shin JI. Dapsone as a potential treatment option for Henoch-Schönlein Purpura (HSP). Med Hypotheses 2017;108:42-5. [PMID: 29055398 DOI: 10.1016/j.mehy.2017.07.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
11 Wozel VE. Innovative use of dapsone. Dermatol Clin 2010;28:599-610. [PMID: 20510768 DOI: 10.1016/j.det.2010.03.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
12 Kast RE. Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness. Springerplus 2015;4:638. [PMID: 26543772 DOI: 10.1186/s40064-015-1441-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Begon E, Chosidow O, Wolkenstein P. Disulone. Annales de Dermatologie et de Vénéréologie 2004;131:1062-73. [DOI: 10.1016/s0151-9638(04)93842-2] [Cited by in Crossref: 11] [Article Influence: 0.6] [Reference Citation Analysis]
14 Molinelli E, Paolinelli M, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone. Expert Opinion on Drug Metabolism & Toxicology 2019;15:367-79. [DOI: 10.1080/17425255.2019.1600670] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 1993;129:507-13. [DOI: 10.1111/j.1365-2133.1993.tb00476.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 88] [Article Influence: 4.9] [Reference Citation Analysis]
16 Scully C, Lo Muzio L. Oral mucosal diseases: Mucous membrane pemphigoid. British Journal of Oral and Maxillofacial Surgery 2008;46:358-66. [DOI: 10.1016/j.bjoms.2007.07.200] [Cited by in Crossref: 62] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
17 Fukae J, Noda K, Fujishima K, Wada R, Yoshiike T, Hattori N, Okuma Y. Successful treatment of relapsing neuro-Sweet's disease with corticosteroid and dapsone combination therapy. Clinical Neurology and Neurosurgery 2007;109:910-3. [DOI: 10.1016/j.clineuro.2007.07.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Cardinali C, Giomi B, Caproni M, Fabbri P. Maculopapular lupus rash in a young woman with systemic involvement. Lupus 2000;9:713-6. [DOI: 10.1191/096120300668126253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
19 Ghaoui N, Hanna E, Abbas O, Kibbi AG, Kurban M. Update on the use of dapsone in dermatology. Int J Dermatol 2020;59:787-95. [PMID: 31909480 DOI: 10.1111/ijd.14761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
20 Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous Lupus Erythematosus: Diagnosis and Management. American Journal of Clinical Dermatology 2003;4:449-65. [DOI: 10.2165/00128071-200304070-00002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
21 Goolamali SI, Macfarlane CS. The use of cimetidine to reduce dapsone-dependent haematological side-effects in a patient with mucous membrane pemphigoid. Clinical and Experimental Dermatology 2009;34:e1025-6. [DOI: 10.1111/j.1365-2230.2009.03710.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Uetrecht JP. METABOLISM OF DRUGS BY LEUKOCYTES. Drug Metabolism and Drug Interactions 1994;11. [DOI: 10.1515/dmdi.1994.11.4.259] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
23 Marietta EV, Rashtak S, Pittelkow MR. Experiences with animal models of dermatitis herpetiformis: a review. Autoimmunity. 2012;45:81-90. [PMID: 21929335 DOI: 10.3109/08916934.2011.606449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Hon KL, Li JTS, Leung AKC, Lee VWY. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics. Expert Opin Pharmacother 2021;22:497-509. [PMID: 32990110 DOI: 10.1080/14656566.2020.1829593] [Reference Citation Analysis]
25 Raap U, V�lker B, Petering H, Hashimoto T, Zillikens D, Kapp A, Werfel T. Erfolgreiche Therapie des IgA-Pemphigus vom subkorneal pustul�sen Typ. Hautarzt 2005;56:66-70. [DOI: 10.1007/s00105-004-0822-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
26 Coleman MD, Smith JK, Perris AD, Buck NS, Seydel JK. Studies on the Inhibitory Effects of Analogues of Dapsone on Neutrophil Function In-vitro. Journal of Pharmacy and Pharmacology 1997;49:53-7. [DOI: 10.1111/j.2042-7158.1997.tb06752.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
27 Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 2008;100:403-11; quiz 412-4, 468. [PMID: 18517070 DOI: 10.1016/S1081-1206(10)60462-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
28 Rhodes L, Tingle M, Park B, Chu P, Verbov J, Friedmann P. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. British Journal of Dermatology 1995;132:257-62. [DOI: 10.1111/j.1365-2133.1995.tb05022.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
29 Arash A, Shirin L. The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid: Treatment of oral MMP. Journal of Oral Pathology & Medicine 2008;37:341-4. [DOI: 10.1111/j.1600-0714.2008.00653.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
30 Pradhan S, Madke B, Kabra P, Singh AL. Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology. Indian J Dermatol 2016;61:469-81. [PMID: 27688434 DOI: 10.4103/0019-5154.190105] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
31 Bagan J, Muzio L, Scully C. Number III Mucous membrane pemphigoid. Oral Diseases 2005;11:197-218. [DOI: 10.1111/j.1601-0825.2005.01140.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
32 Elder MJ, Leonard J, Dart JK. Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid. Br J Ophthalmol 1996;80:549-52. [PMID: 8759268 DOI: 10.1136/bjo.80.6.549] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
33 Grabbe J, Haas N, Möller A, Henz B. Erythema elevatum diutinum - evidence for disease-dependent leucocyte alterations and response to dapsone. British Journal of Dermatology 2000;143:415-20. [DOI: 10.1046/j.1365-2133.2000.03673.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
34 Nürnberg W, Grabbe J, Czarnetzki BM. Synergistic effects of pentoxifylline and dapsone in leucocytoclastic vasculitis. Lancet 1994;343:491. [PMID: 7906000 DOI: 10.1016/s0140-6736(94)92746-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
35 Kanoh S, Tanabe T, Rubin BK. Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret. Chest. 2011;140:980-990. [PMID: 21436242 DOI: 10.1378/chest.10-2908] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
36 Ogino T, Tsuji K, Tojo T, Igari N, Seki N, Sudo Y, Manda T, Nishigaki F, Matsuo M. Discovery of FR115092 : A novel antinephritic agent. Bioorganic & Medicinal Chemistry Letters 1998;8:75-80. [DOI: 10.1016/s0960-894x(97)10192-5] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
37 Schmidt E, Reimer S, Kruse N, Bröcker EB, Zillikens D. The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin Exp Immunol 2001;124:157-62. [PMID: 11359455 DOI: 10.1046/j.1365-2249.2001.01503.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
38 Elder MJ, Lightman S. The immunological features and pathophysiology of ocular cicatricial pemphigoid. Eye (Lond) 1994;8 ( Pt 2):196-9. [PMID: 7958021 DOI: 10.1038/eye.1994.45] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
39 Ji Y, McLandsborough L, Kondagunta A, Cleary PP. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 1996;64:503-10. [PMID: 8550199 DOI: 10.1128/iai.64.2.503-510.1996] [Cited by in Crossref: 174] [Cited by in F6Publishing: 86] [Article Influence: 7.0] [Reference Citation Analysis]
40 Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res 2014;306:103-24. [PMID: 24310318 DOI: 10.1007/s00403-013-1409-7] [Cited by in Crossref: 160] [Cited by in F6Publishing: 102] [Article Influence: 20.0] [Reference Citation Analysis]
41 Kunte C, Loeser C, Wolff H. Folliculitis spinulosa decalvans: Successful therapy with dapsone. Journal of the American Academy of Dermatology 1998;39:891-3. [DOI: 10.1016/s0190-9622(98)70374-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
42 Coleman MD, Thorpe S, Lewis S, Buck NS, Perris AD, Seydel JK. Preliminary evaluation of the toxicity and efficacy of novel 2,4-diamino-5-benzylpyrimidine-sulphone derivatives using rat and human tissues in vitro. Environmental Toxicology and Pharmacology 1996;2:389-95. [DOI: 10.1016/s1382-6689(96)00076-2] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
43 Sabbagh DK, Barmayehvar B, Nguyen T, Edgar RG, Turner AM. Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment. WJD 2018;7:1-8. [DOI: 10.5314/wjd.v7.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
44 Ji Y, Carlson B, Kondagunta A, Cleary PP. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect Immun 1997;65:2080-7. [PMID: 9169735 DOI: 10.1128/iai.65.6.2080-2087.1997] [Cited by in Crossref: 114] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
45 Culton DA, Diaz LA. Treatment of subepidermal immunobullous diseases. Clin Dermatol 2012;30:95-102. [PMID: 22137232 DOI: 10.1016/j.clindermatol.2011.03.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
46 Pickert A, Raimer S. An evaluation of dapsone gel 5% in the treatment of acne vulgaris. Expert Opinion on Pharmacotherapy 2009;10:1515-21. [DOI: 10.1517/14656560903002097] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
47 Salem I, Kimak M, Conic R, Bragazzi NL, Watad A, Adawi M, Bridgewood C, Pacifico A, Santus P, Rizzi M, Petrou S, Colombo D, Fiore M, Pigatto PDM, Damiani G. Neutrophilic Dermatoses and Their Implication in Pathophysiology of Asthma and Other Respiratory Comorbidities: A Narrative Review. Biomed Res Int 2019;2019:7315274. [PMID: 31281845 DOI: 10.1155/2019/7315274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
48 Miyachi Y. Pharmacologic modulation of neutrophil functions. Clinics in Dermatology 2000;18:369-73. [DOI: 10.1016/s0738-081x(99)00128-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
49 Kapiotis S, Sengoelge G, Sperr W, Baghestanian M, Quehenberger P, Bevec D, Li S, Menzel E, Mühl A, Zapolska D, Virgolini I, Valent P, Speiser W. Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cells. Life Sciences 1996;58:2167-81. [DOI: 10.1016/0024-3205(96)00210-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
50 Gürcan HM, Ahmed AR. Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data. American Journal of Clinical Dermatology 2009;10:383-96. [DOI: 10.2165/11310740-000000000-00000] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
51 Coleman MD. Dapsone toxicity: some current perspectives. Gen Pharmacol 1995;26:1461-7. [PMID: 8690232 DOI: 10.1016/0306-3623(95)00029-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
52 Grayson PC, Schauer C, Herrmann M, Kaplan MJ. Review: Neutrophils as Invigorated Targets in Rheumatic Diseases. Arthritis Rheumatol 2016;68:2071-82. [PMID: 27159737 DOI: 10.1002/art.39745] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
53 Kemppainen E, Salmi T, Lindfors K. Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis. Front Immunol 2021;12:657280. [PMID: 33854513 DOI: 10.3389/fimmu.2021.657280] [Reference Citation Analysis]
54 Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol. 2011;64:1027-133; quiz 1027-133;. [PMID: 21571168 DOI: 10.1016/j.jaad.2010.09.776] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
55 Nicolas ME, Krause PK, Gibson LE, Murray JA. Dermatitis herpetiformis. Int J Dermatol 2003;42:588-600. [PMID: 12890100 DOI: 10.1046/j.1365-4362.2003.01804.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
56 Stafslien DK, Cleary PP. Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate. J Bacteriol 2000;182:3254-8. [PMID: 10809707 DOI: 10.1128/JB.182.11.3254-3258.2000] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
57 Merlo G, Cozzani E, Russo R, Parodi A. Dapsone for Unresponsive Granulomatous Rosacea. Am J Ther 2020;27:e304-6. [PMID: 30946045 DOI: 10.1097/MJT.0000000000000903] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kast RE. Dapsone as treatment adjunct in ARDS. Exp Lung Res 2020;46:157-61. [PMID: 32286085 DOI: 10.1080/01902148.2020.1753266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
59 Thornhill M, Pemberton M, Buchanan J, Theaker E. An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoid. Br J Dermatol 2000;143:117-26. [PMID: 10886145 DOI: 10.1046/j.1365-2133.2000.03600.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
60 Zhu Y, Stiller MJ. Dapsone and sulfones in dermatology: Overview and update. Journal of the American Academy of Dermatology 2001;45:420-34. [DOI: 10.1067/mjd.2001.114733] [Cited by in Crossref: 256] [Cited by in F6Publishing: 161] [Article Influence: 12.8] [Reference Citation Analysis]
61 Suda T, Suzuki Y, Matsui T, Inoue T, Niide O, Yoshimaru T, Suzuki H, Ra C, Ochiai T. Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. Br J Dermatol. 2005;152:887-895. [PMID: 15888142 DOI: 10.1111/j.1365-2133.2005.06559.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
62 Yu H, Park J, Park J, Hwang D, Park Y. A Case of Childhood Generalized Pustular Psoriasis Treated with Dapsone. The Journal of Dermatology 2001;28:316-9. [DOI: 10.1111/j.1346-8138.2001.tb00140.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
63 Sams HH, Dunnick CA, Smith ML, King LE. Necrotic arachnidism. Journal of the American Academy of Dermatology 2001;44:561-76. [DOI: 10.1067/mjd.2001.112385] [Cited by in Crossref: 90] [Cited by in F6Publishing: 58] [Article Influence: 4.5] [Reference Citation Analysis]
64 Leslie KS, Gaffney K, Ross CN, Ridley S, Barker TH, Garioch JJ. A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis: Dapsone hypersensitivity. Clinical and Experimental Dermatology 2003;28:496-8. [DOI: 10.1046/j.1365-2230.2003.01336.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
65 Chang DJ, Lamothe M, Stevens RM, Sigal LH. Dapsone in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 1996;25:390-403. [DOI: 10.1016/s0049-0172(96)80004-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
66 Wolf R, Tuzun B, Tuzun Y. Dapsone: unapproved uses or indications. Clinics in Dermatology 2000;18:37-53. [DOI: 10.1016/s0738-081x(99)00093-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
67 Mufti A, Mirali S, Abduelmula A, McDonald KA, Alabdulrazzaq S, Sachdeva M, Yeung J. Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature. JAAD Int 2021;3:79-87. [PMID: 34409375 DOI: 10.1016/j.jdin.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Van Luyn MJA, Van Wachem PB, Leta R, Blaauw EH, Nieuwenhuis P. Modulation of the tissue reaction to biomaterials: Part I Biocompatibility of crosslinked dermal sheep collagens after macrophage depletion. J Mater Sci: Mater Med 1994;5:671-8. [DOI: 10.1007/bf00120354] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
69 Altschuler EL, Kast RE. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS). Med Hypotheses 2020;141:109774. [PMID: 32344275 DOI: 10.1016/j.mehy.2020.109774] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
70 Görög A, Antiga E, Caproni M, Cianchini G, De D, Dmochowski M, Dolinsek J, Drenovska K, Feliciani C, Hervonen K, Lakos Jukic I, Kinyó Á, Koltai T, Korponay-Szabó I, Marzano AV, Patsatsi A, Rose C, Salmi T, Schmidt E, Setterfield J, Shahid M, Sitaru C, Uzun S, Valitutti F, Vassileva S, Yayli S, Sárdy M. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 2021;35:1251-77. [PMID: 34004067 DOI: 10.1111/jdv.17183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
71 Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, Sheikh J, Weldon D, Zuraw B, Bernstein DI, Blessing-moore J, Cox L, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D. The diagnosis and management of acute and chronic urticaria: 2014 update. Journal of Allergy and Clinical Immunology 2014;133:1270-1277.e66. [DOI: 10.1016/j.jaci.2014.02.036] [Cited by in Crossref: 336] [Cited by in F6Publishing: 247] [Article Influence: 48.0] [Reference Citation Analysis]
72 Geyfman M, Debabov D, Poloso N, Alvandi N. Mechanistic insight into the activity of a sulfone compound dapsone on Propionibacterium (Newly Reclassified as Cutibacterium ) Acnes- mediated cytokine production. Exp Dermatol 2019;28:190-7. [DOI: 10.1111/exd.13869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Sago J, Hall RP. Dapsone. Dermatol Ther 2002;15:340-51. [DOI: 10.1046/j.1529-8019.2002.01543.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
74 Noda S, Asano Y, Sato S. Long-term complete resolution of severe chronic idiopathic urticaria after dapsone treatment: Letters to the Editor. The Journal of Dermatology 2012;39:496-7. [DOI: 10.1111/j.1346-8138.2011.01310.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Takahashi H, Fukami Y, Honma M, Ishida-yamamoto A, Iizuka H. Successful combination therapy with dapsone and cyclosporine for erythema elevatum diutinum with unusual appearance: Letters to the Editor. The Journal of Dermatology 2012;39:486-7. [DOI: 10.1111/j.1346-8138.2011.01331.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
76 Kast RE, Lefranc F, Karpel-Massler G, Halatsch ME. Why dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma. Br J Neurosurg 2012;26:813-7. [PMID: 22551309 DOI: 10.3109/02688697.2012.674577] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
77 Moksha L, Halder N, Singh SB, Chawla R, Kumar A, Velpandian T. Pharmacoproteomic analysis of topical dapsone and prednisolone interventions in the aqueous humor of anterior uveitis. Exp Eye Res 2021;206:108534. [PMID: 33722510 DOI: 10.1016/j.exer.2021.108534] [Reference Citation Analysis]
78 Ciarrocca KN, Greenberg MS. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 1999;88:159-63. [DOI: 10.1016/s1079-2104(99)70110-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
79 Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:517-34. [PMID: 9394385 DOI: 10.1016/s1079-2104(97)90269-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
80 Watanabe J, Shimamoto J, Kotani K. The Effects of Antibiotics for Helicobacter pylori Eradication or Dapsone on Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 2021;10:156. [PMID: 33557074 DOI: 10.3390/antibiotics10020156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
81 Thuong-nguyen V, Kadunce DP, Hendrix JD, Gammon WR, Zone JJ. Inhibition of Neutrophil Adherence to Antibody by Daspone: A Possible Therapeutic Mechanism of Dapsone in the Treatment of IgA Dermatoses. Journal of Investigative Dermatology 1993;100:349-55. [DOI: 10.1111/1523-1747.ep12471811] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis]